China Universal Asset Management Company’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$189K Sell
5,503
-829
-13% -$24.4K 0.01% 358
2026
Q1
$196K Buy
6,332
+282
+5% +$6.94K 0.01% 354
2025
Q4
$126K Sell
6,050
-830
-12% -$15.4K 0.01% 392
2025
Q3
$108K Buy
6,880
+3,130
+83% +$64.6K 0.01% 383
2025
Q2
$74.5K Buy
3,750
+791
+27% +$16K 0.01% 389
2025
Q1
$52.4K Sell
2,959
-169
-5% -$5.51K ﹤0.01% 417
2024
Q4
$144K Buy
+3,128
New +$132K 0.01% 356
2022
Q4
Sell
-34
Closed 477
2022
Q3
$0 Buy
+34
New +$377 ﹤0.01% 466

Other funds holding TECX

China Universal Asset Management Company's TECX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Tectonic Therapeutic (TECX) stake by 13% in Q2 2026, selling an estimated $24.4K and leaving 5,503 shares worth $189K. The position accounts for 0.01% of the portfolio, ranked #358.

China Universal Asset Management Company first reported a position in TECX in Q3 2022 and has held it in 8 quarters since. The position peaked at $196K in Q1 2026. 14 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • China Universal Asset Management Company held 5,503 shares of Tectonic Therapeutic worth $189K as of Q2 2026.
  • China Universal Asset Management Company sold 829 Tectonic Therapeutic shares in Q2 2026, an estimated $24.4K.
  • Tectonic Therapeutic made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #358 holding.
  • China Universal Asset Management Company first reported a position in Tectonic Therapeutic in Q3 2022 and has held it in 8 quarters since.
  • China Universal Asset Management Company's Tectonic Therapeutic position peaked at $196K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.